Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma

Clinical trial NCT00923351 · COMPLETED

Trial details

NCT number: NCT00923351
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neuroblastoma Sarcoma Rhabdomyosarcoma-Embryonal Rhabdomyosarcoma- Alveolar Neuroectodermal Tumors, Primitive, Peripheral

Start date: 2007-06-02
Primary completion: 2012-08-30
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.